Mode
Text Size
Log in / Sign up
N/A N=157 Randomized Triple-blind Treatment

Improving Treatment Outcomes for Suicidal Veterans With PTSD

Suicidal Ideation · Suicide, Attempted · Ptsd

Enrolled (actual)
157
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Change in Suicide Ideation — 5.91; 6.37; 3.67; 2.47 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive Processing Therapy (CPT) (Behavioral); Crisis Response Plan (CRP) (Behavioral); Safety Planning Intervention (SPI) (Behavioral); Narrative Assessment (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Ohio State University
Primary completion
Dec 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Suicide Ideation
5.91; 6.37; 3.67; 2.47; 3.00; 2.25
PRIMARY
Percent With Follow-up Suicidal Behaviors
4; 3
PRIMARY
Number of Follow-up Suicidal Behaviors
8; 4
SECONDARY
Change in PTSD Symptoms
27.01; 25.93; 17.57; 18.05; 13.42; 13.06

Summary

The efficacy of cognitive processing therapy (CPT) for reducing the symptoms of posttraumatic stress disorder (PTSD) across populations including military personnel and veterans is well supported. CPT also contributes to significant and rapid reductions in suicide ideation among people diagnosed with PTSD, although available evidence suggests this effect decays over time. Studies also show that approximately 1 in 6 people who begin CPT without suicide ideation will subsequently report suicidal thoughts at some point during or soon after completing treatment. Research focused on improving CPT's effects on suicide risk is therefore warranted. The primary aim of this study is to determine if the integration of a crisis response plan (CRP)--an empirically-supported procedure for reducing suicide ideation and attempts--can lead to faster reductions in suicide ideation among acutely suicidal veterans receiving CPT and prevent the development of suicide ideation among veterans who begin CPT without suicide ideation.

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Current or prior service in the U.S. military
  • Current diagnosis of PTSD or subthreshold PTSD
  • Ability to speak and understand the English language
  • Ability to complete the informed consent process.

Exclusion Criteria

  • Substance use disorder requiring medical management
  • Imminent suicide risk warranting inpatient hospitalization or suicide-focused treatment
  • Impaired mental status that precludes the ability to provide informed consent (e.g., intoxication, psychosis, mania)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04690582). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search